Low serum paraoxonase: a risk factor for atherosclerotic disease?
- 1 May 1999
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 119-120, 389-397
- https://doi.org/10.1016/s0009-2797(99)00050-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.Journal of Clinical Investigation, 1997
- Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.Journal of Clinical Investigation, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- Paraoxonase gene polymorphism in Japanese subjects with coronary heart diseaseInternational Journal of Cardiology, 1996
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- Multiple Genetic Determinants of Variation of Plasma Lipoproteins in Alberta HutteritesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- HDL, its enzymes and its potential to influence lipid peroxidationAtherosclerosis, 1995
- A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic IsolateArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993